Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Percell Biolytica Aktiebolag
AB
Active
Org 5562990134
Kalvögatan 43, 257 30
Rydebäck
Manufacture of other organic basic chemicals
·
NACE 2014
Est. 1987 · 39 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of other organic basic chemicals
/
Percell Biolytica Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
11M
8M
6M
3M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 9M (+800% vs 2022)
9M
+800%
2023
2024: 6M (-33% vs 2023)
6M
-33%
2024
2025: 5M (-17% vs 2024)
5M
-17%
2025
EBITDA
SEK millions
10M
6M
3M
0M
-4M
2021: -1M
-1M
2021
2022: -1M (0% vs 2021)
-1M
0%
2022
2023: 7M (+800% vs 2022)
7M
+800%
2023
2024: 5M (-29% vs 2023)
5M
-29%
2024
2025: 3M (-40% vs 2024)
3M
-40%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
4 725
5 810
9 058
526
1 466
Staff expenses
−713
−62
—
—
—
EBITDA
3 183
4 839
6 875
−1 304
−862
Depreciation & amort.
−262
−127
−81
−76
−70
EBIT
2 922
4 712
6 794
−1 380
−932
Net financials
70
81
42
2 353
239
Profit before tax
447
240
104
2 288
18
Tax
−92
−82
−38
−0
−17
Net profit
355
158
66
2 288
1
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
5 820
5 188
5 003
11 186
10 311
Equity
565
1 610
1 452
7 385
6 097
Long-term debt
—
—
0
0
0
Short-term debt
5 255
3 497
1 364
1 196
1 294
Total debt
5 255
3 497
1 364
1 196
1 294
Financial ratios
5-year trend
EBITDA margin
67,4 %
This company
15,8 %
Market median
This company
Market median
327% above market
2021
2025
Equity ratio
9,7 %
This company
38,2 %
Market median
This company
Market median
75% below market
2021
2025
Return on equity
62,8 %
This company
18,4 %
Market median
This company
Market median
241% above market
2021
2025
Net profit margin
7,5 %
This company
8,1 %
Market median
This company
Market median
7% below market
2021
2025
Asset turnover
0,81×
This company
1,12×
Market median
This company
Market median
28% below market
2021
2025
Debt / equity
9,31×
This company
0,62×
Market median
This company
Market median
>999% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
More on Percell Biolytica Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
